Sacral Tumors: Regional Challenges




Summary of Key Points





  • Percutaneous computed tomography–guided biopsy should be performed in patients when diagnosis may influence the decision to proceed with surgery or the extent of surgery.



  • It is critical that wide negative margins are obtained in tumor resection.



  • Adjuvant therapy with proton beam or intensity-modulated radiation therapy is used for contaminated margins or incomplete resections.



  • Optimal wound closure is critical, and the surgical team should consider the utilization of plastic surgery flaps such as the vertical rectus abdominis myocutaneous flap.



Tumors of the sacrum are rare, accounting for 1% to 7% of all tumors of the spine. Vague clinical presentations, insidious growth, complex exposures, and proximity to nervous, skeletal, vascular, colorectal, and genitourinary structures make sacral tumors challenging to treat. Surgical therapy can range from palliative debulking to curative en bloc resections depending on the pathology and extent of invasion. Surgical planning often requires balancing functional and neurologic preservation with cure of the disease process. This chapter focuses on regional challenges in diagnosis and surgical management specific to the unique anatomy of the sacrum.




Tumor Classification


Optimal treatment strategies depend heavily on the extent of invasion, involvement of neighboring structures, and pathologic diagnosis. Low-grade malignancies, isolated sarcomas, and benign tumors may be cured with en bloc or intralesional resection, whereas metastatic lesions often require debulking procedures for palliation. Sciubba and colleagues classified sacral tumors into fout general categories: metastatic, congenital, primary osseous, and primary neurogenic.


Metastatic Tumors


Following the lungs and liver, the skeleton is the third most common site of metastasis with spinal involvement occurring in 5% to 10% of all cases. Metastatic spread of distant primary tumors represents the most common neoplasms in the spinal axis including the sacrum. Common sources include lung, breast, prostate, renal, and thyroid tumors, which spread hematologically. Sacral metastases are typically osteolytic except cases of breast and prostate primaries, which are often osteoblastic. Hematologic malignancies such as multiple myeloma and lymphoma can occur in the sacrum via metastasis or as primary sites. Furthermore, the sacrum may be involved from locally invasive tumors such as rectal adenocarcinomas.


The diagnosis of metastasis often occurs earlier than it does for other tumors of the sacrum due to their rapid growth, causing low back pain and radicular symptoms. However, sacral involvement often signifies advanced metastatic disease with treatment options limited to chemotherapy or radiation. In such cases, surgery is limited to palliative decompression of neural or pelvic structures. In select cases, an extended abdominoperineal resection or pelvic exenteration involving a sacrectomy for locally invasive pelvic tumors may be indicated.


Congenital Lesions


Congenital lesions of the sacrum include dermoid cysts, sacral meningoceles, perineural (Tarlov) cysts, teratomas, hamartomas, and chordomas. Chordomas are the most common primary bone tumor of the sacrum, arising from notochordal rests. Chordomas occur mostly in individuals between the ages of 40 to 70 and have a 2 : 1 male-to-female predominance with approximately 50% to 60% occurring in the sacrum. They are slow-growing, locally invasive lesions that often present with sacral pain or symptoms secondary to sacral nerve root compression such as sciatic pain, leg weakness, and bowel/bladder dysfunction. En bloc resection is often curative and is the major determinant of disease-free survival. The sacrectomy should extend one entire sacral segment beyond the diseased portion rostrally and caudally.


Primary Osseous Tumors


Primary osseous tumors account for less than 10% of all primary bone tumors and can be divided into low-grade, high-grade, and benign lesions. Low-grade lesions include osteoid osteomas, osteoblastomas, osteochondromas, and aneurysmal bone cysts and are often discovered incidentally. When symptomatic, osteoid osteomas can produce localizing pain that is worse at night and often relieved with salicylates. Osteoblastomas are histologically similar to osteoid osteomas but measure greater than 2 cm in diameter and typically present with a dull, poorly localized ache.


Aneurysmal bone cysts occur mostly in children and can present with back pain. Extensive lesions can cause significant sacral destruction and symptoms secondary to sacral nerve root compression. Aneurysmal bone cysts may resolve spontaneously, but in severely symptomatic cases they may be treated successfully with selective arterial embolization. Subtotal resection and intralesional curettage of osteoid osteomas and osteoblastomas are effective in treating symptoms but have a higher likelihood of recurrence compared with total resection.


High-grade osseous tumors of the sacrum are typically sarcomas, which include chondrosarcoma, osteosarcoma, and Ewing sarcoma. Sacral chondrosarcomas have a male predominance, typically occur between 30 and 70 years, and can be divided into primary (arising de novo) or secondary (malignant transformation of enchondroma or osteochondroma). Osteosarcomas are high-grade lesions that most frequently involve the lumbosacral spine. Primary osteosarcomas arise de novo and affect men in the fourth decade of life, whereas secondary lesions occur in individuals with a history of radiation and from malignant transformation of giant cell tumors or Paget disease. Wide local excision is advised in amenable cases, as these lesions are typically resistant to chemotherapy and radiation. Despite adequate excision, the mean survival for patients with chondrosarcoma and osteosarcoma is 6 years and 10 months, respectively.


Primary Ewing sarcoma is a high-grade tumor histologically composed of small, round cells that affects the spine in 3% to 10% of cases, with a predilection for the sacral ala. These lesions are typically sensitive to chemotherapy and radiation. The addition of surgical resection has been suggested to improve survival.


Giant cell tumors are histologically benign, slow-growing tumors of young adults, often affecting the sacrum. These lesions often attain a large size due to their indolent growth and present with pain and symptoms of neurologic compression. Response to radiation is variable and has been reported to lead to sarcomatous degeneration. Total resection is preferred, as giant cell tumors have a high rate of recurrence and may require total sacrectomy when the tumor crosses the midline. These tumors also have a tendency to involve the upper sacral segments and the sacroiliac joints. Successful treatment has also been reported with intralesional curettage with bone cement implantation and cryotherapy.


Primary Neurogenic Tumors


Primary neurogenic tumors, which include schwannomas, neurofibromas, ependymomas, and ganglioneuromas, rarely involve the sacrum. Similar to the rest of the spine, sacral schwannomas and neurofibromas are slow growing, benign nerve sheath tumors that may have intra- and extradural components. They often grow through a neural foramen leading to a dumbbell shape or they can fill the spinal canal, leading to sacral nerve root dysfunction. Most tumors can be resected from a posterior, intradural approach. However, when there is a significant presacral component, an anterior approach may be warranted.


Sacral ependymomas are most commonly myxopapillary histologic variants. These can be intra- or extradural and can cause significant sacral erosion before diagnosis. En bloc resection is curative and can avoid cerebrospinal fluid (CSF) dissemination. Ganglioneuromas arise from sympathetic nerves and can rarely grow ventral to the sacrum along the sympathetic chain. Extension through the neural foramen can lead to sacral nerve root compression. Complete excision may require a combined anterior-posterior approach.




Diagnosis


Anatomic idiosyncrasies of the sacrum, vague symptoms, slow growth, and rarity make timely diagnosis of sacral tumors challenging. Low back pain is often the initial presenting symptom, which may be mistakenly attributed to lumbosacral degenerative disc disease. Furthermore, standard magnetic resonance imaging (MRI) and computed tomography (CT) imaging of the lumbosacral spine frequently excludes the lower sacrum and coccyx. An ideal study using MRI with gadolinium should clearly delineate the interaction of the sacral lesion with neural structures as well as visceral and vascular structures of the pelvis. Likewise, an optimal CT study should capture the full bone involvement of the lesion and provide enough information for eventual reconstruction plans after tumor resection.




Clinical Presentation


Although certain aggressive sacral tumors can become symptomatic early in the disease course, most sacral tumors are slow growing. Thus, these lesions can grow to large sizes before diagnostic workup is initiated ( Fig. 121-1 ). One study, published in 1961, reported an average delay of 3.2 years between symptom onset and operative management in 100 caudal spinal tumors, the majority of which arose from the filum termiale. Diagnostic modalities have improved since then, but given the delayed presentation of neurologic deficits and the subtle findings on MRI, diagnosis of sacral tumors still is delayed. Back pain is often the initial manifestation with the development of neurologic symptoms depending on the pattern of tumor growth and infiltration.




Figure 121-1


Large sacral tumor compressing the rectum.


Localizing pain from a sacral tumor is often present or more intense at night and exacerbated by Valsalva maneuvers. The majority of patients present with back or radicular pain that can mimic symptoms of lumbosacral spondylosis. Compression of the gastrointestinal or genitourinary tract may lead to obstructive symptoms, whereas invasion of the sacroiliac or pelvic joint can cause pain exacerbated by upright posture.




Diagnostic Imaging


Due to low cost and accessibility, plain radiographs are often the initial diagnostic imaging modality obtained in the workup of potential sacral tumors. The slope of the sacrum, overlying abdominal and peritoneal viscera, bowel gas, and fecal contents make plain radiographs of the pelvis and sacrum difficult to obtain and interpret. Abnormalities discovered on radiographs or cases with high suspicion should be further investigated with CT and MRI of the pelvis and sacral spine. CT and MRI findings of various sacral lesions have been previously described ( Tables 121-1 and 121-2 ).



TABLE 121-1

Characteristic Findings on Radiographic and CT Imaging


















































































Tumor Lytic Location & Shape Calcification Rim
Giant cell tumor Yes Crosses midline Thin
Osteoid osteoma Yes (olive pit sign) Varies Yes Sclerotic bed
Osteoblastoma (less aggressive) Yes Expanded in anterior column Yes, multiple Sclerotic
Osteoblastoma (more aggressive) Yes Invades soft tissue No No
Nerve sheath tumors Yes Expansive, dumbbell shaped Yes, heterogeneous Erodes neural foramen
Hemangioma Yes Multiple lesions: lytic, trabecular, or honeycombed Yes Sclerotic
Osteochondroma No Cauliflower-like growth Yes, equal to bone No
Chordoma Yes Central with invasion bone and soft tissue Yes, peripheral No
Multiple myeloma Yes Diffuse, multiple round lesions No No
Chondrosarcoma Yes (mild) Lateral, invades bone and soft tissue Yes, rounded and irregular No
Angiosarcoma Yes Multiple lesions Nonspecific Nonspecific
Aneurysmal bone cyst Yes Lateral No Bone

Modified from Sciubba DM, Petteys RJ, Garces-Ambrossi GL, et al: Diagnosis and management of sacral tumors. J Neurosurg Spine 10:244–256, table 1, 2009.


TABLE 121-2

Characteristic MRI Findings of Sacral Tumors










































































Tumor T1 Signal T2 Signal Signal Distribution Enhancement Edema
Giant cell tumor Low, intermediate Low Heterogeneous, capsule variable Yes (mild) No
Osteoblastoma Low, intermediate Intermediate, high Variable, may be lobulated No Peritumoral soft tissue and marrow
Nerve sheath tumor Nonspecific Low signal center, high signal periphery Heterogeneous No No
Hemangioma High Intermediate Honeycombed or trabecular radiations Yes No
Osteochondroma Identical to bone Identical to bone Homogeneous with high signal thick cartilage cap No No
Chordoma Isointense to muscle Very high Heterogeneous Yes No
Multiple myeloma Hypointense to bone Intermediate Yes
Chondrosarcoma Low, intermediate Very high Homogeneous Yes (septated) No
Aneurysmal bone cyst Nonspecific Multiloculated, vertical fluid levels High signal in dependent or independent compartment Yes (septated) No

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 12, 2019 | Posted by in NEUROSURGERY | Comments Off on Sacral Tumors: Regional Challenges

Full access? Get Clinical Tree

Get Clinical Tree app for offline access